Statera Biopharma Announces FDA Lifts Clinical Hold on Entolimod

NEXT STORY
Arch Biopartners’ Lead Drug LSALT Peptide to Enter the Canadian Treatments for COVID-19 (CATCO) Trial
PREV STORY
Sigyn Therapeutics Reports the Successful Completion of a Study to Address Gram-Positive Bacterial Toxins Associated with Sepsis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property

Mayfield, a women’s health focused drug development company, intends to seek FDA approval for ...

author_avatar
NASDAQ Market News

BriaCell Continues Business and Clinical Operations During COVID-19 Pandemic

author_avatar
NASDAQ Market News

Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

author_avatar
NASDAQ Market News